$37,500 of AMGEN INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the pharmaceutical industry."
You can find more data on corporate lobbying on Quiver Quantitative.
AMGN Congressional Stock Trading
Members of Congress have traded $AMGN stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $AMGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/03.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 10/24, 09/11 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/25.
- SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 09/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AMGN Insider Trading Activity
AMGN insiders have traded $AMGN stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $AMGN stock by insiders over the last 6 months:
- MURDO GORDON (EVP, Global Commercial Ops) sold 6,879 shares for an estimated $2,317,071
- NANCY A. GRYGIEL (SVP & CCO) has made 0 purchases and 3 sales selling 4,406 shares for an estimated $1,434,946.
- RACHNA KHOSLA (SVP, Business Development) sold 890 shares for an estimated $299,255
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMGN Hedge Fund Activity
We have seen 1,237 institutional investors add shares of AMGN stock to their portfolio, and 1,276 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,816,157 shares (+72.2%) to their portfolio in Q3 2025, for an estimated $1,076,919,505
- CAPITAL WORLD INVESTORS added 1,935,876 shares (+11.5%) to their portfolio in Q3 2025, for an estimated $546,304,207
- PRIMECAP MANAGEMENT CO/CA/ removed 924,100 shares (-8.7%) from their portfolio in Q3 2025, for an estimated $260,781,020
- NATIONAL BANK OF CANADA /FI/ added 866,166 shares (+240.5%) to their portfolio in Q3 2025, for an estimated $244,432,045
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 656,935 shares (+5.1%) to their portfolio in Q3 2025, for an estimated $185,387,057
- PERRITT CAPITAL MANAGEMENT INC removed 599,055 shares (-99.6%) from their portfolio in Q3 2025, for an estimated $169,053,321
- WOODTRUST FINANCIAL CORP removed 588,232 shares (-98.8%) from their portfolio in Q3 2025, for an estimated $165,999,070
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMGN Analyst Ratings
Wall Street analysts have issued reports on $AMGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 12/03/2025
- Piper Sandler issued a "Overweight" rating on 11/14/2025
- B of A Securities issued a "Underperform" rating on 09/26/2025
To track analyst ratings and price targets for AMGN, check out Quiver Quantitative's $AMGN forecast page.
AMGN Price Targets
Multiple analysts have issued price targets for $AMGN recently. We have seen 10 analysts offer price targets for $AMGN in the last 6 months, with a median target of $318.0.
Here are some recent targets:
- Gregory Renza from Truist Securities set a target price of $319.0 on 01/08/2026
- Michael Yee from UBS set a target price of $380.0 on 01/07/2026
- Terence Flynn from Morgan Stanley set a target price of $304.0 on 12/12/2025
- Mohit Bansal from Wells Fargo set a target price of $325.0 on 12/10/2025
- Evan David Seigerman from BMO Capital set a target price of $372.0 on 12/03/2025
- David Amsellem from Piper Sandler set a target price of $381.0 on 11/14/2025
- Carter Gould from Cantor Fitzgerald set a target price of $315.0 on 11/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
